{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Dibromoacetic acid", "Hippocampus", "Neuroinflammation response", "Neurotoxicity", "Oxidative stress", "Pre-frontal cortex"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "28844098", "DateCompleted": {"Year": "2018", "Month": "07", "Day": "03"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2017", "Month": "08", "Day": "26"}], "ELocationID": ["10.1007/s11011-017-0095-0"], "Journal": {"ISSN": "1573-7365", "JournalIssue": {"Volume": "32", "Issue": "6", "PubDate": {"Year": "2017", "Month": "Dec"}}, "Title": "Metabolic brain disease", "ISOAbbreviation": "Metab Brain Dis"}, "ArticleTitle": "The toxic influence of dibromoacetic acid on the hippocampus and pre-frontal cortex of rat: involvement of neuroinflammation response and oxidative stress.", "Pagination": {"StartPage": "2009", "EndPage": "2019", "MedlinePgn": "2009-2019"}, "Abstract": {"AbstractText": ["Dibromoacetic acid (DBA) exsits in drinking water as a by-product of disinfection as a result of chlorination or ozonation processes. Hippocampus and pre-frontal cortex are the key structures in memory formation and weanling babies are more sensitive to environmental toxicant than adults, so this study was conducted to evaluate the potential neurotoxicity effects of DBA exposure when administered intragastrically for 4\u00a0weeks to weanling Sprague-Dawley rats, at concentration of 0, 20, 50, 125\u00a0mg/kg via the neurobehavioral and neurochemical effects. Results indicated that animals weight gain and food consumption were not significantly affected by DBA. However, morris water maze test showed varying degrees of changes between control and high-dose group. Additionally, the level of malondialdehyde (MDA) and generation of reactive oxygen species (ROS) in the hippocampus and pre-frontal cortex of rats increased significantly. The activities of total superoxide dismutase (SOD) and the glutathione (GSH) content in the hippocampus and pre-frontal cortex of rats decreased significantly after treatment with DBA. Treatment with DBA increased the protein and mRNA expression of Iba-1, NF-\u03baB, TNF-\u03b1, IL-6, IL-1\u03b2 and HO-1 in the hippocampus and pre-frontal cortex of rats. These data suggested that DBA had a toxic influence on the hippocampus and pre-frontal cortex of rats, and that the mechanism of toxicity might be associated with the neuroinflammation response and oxidative stress."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology, College of Public Health, Harbin Medical University, Harbin, Heilongjiang Province, 150081, People's Republic of China."}], "LastName": "Jiang", "ForeName": "Wenbo", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology, College of Public Health, Harbin Medical University, Harbin, Heilongjiang Province, 150081, People's Republic of China."}], "LastName": "Li", "ForeName": "Bai", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology, College of Public Health, Harbin Medical University, Harbin, Heilongjiang Province, 150081, People's Republic of China."}], "LastName": "Chen", "ForeName": "Yingying", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology, College of Public Health, Harbin Medical University, Harbin, Heilongjiang Province, 150081, People's Republic of China. hmushuyinggao@163.com."}], "LastName": "Gao", "ForeName": "Shuying", "Initials": "S"}], "GrantList": [{"GrantID": "30901206", "Agency": "National Nature Science Foundation of China", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Metab Brain Dis", "NlmUniqueID": "8610370", "ISSNLinking": "0885-7490"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Acetates"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "4Y8F71G49Q", "NameOfSubstance": "Malondialdehyde"}, {"RegistryNumber": "7FUW62YY5L", "NameOfSubstance": "dibromoacetic acid"}, {"RegistryNumber": "EC 1.15.1.1", "NameOfSubstance": "Superoxide Dismutase"}, {"RegistryNumber": "GAN16C9B8O", "NameOfSubstance": "Glutathione"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Acetates"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Encephalitis"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["metabolism"], "DescriptorName": "Glutathione"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Hippocampus"}, {"QualifierName": ["drug effects"], "DescriptorName": "Lipid Peroxidation"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["metabolism"], "DescriptorName": "Malondialdehyde"}, {"QualifierName": ["drug effects"], "DescriptorName": "Maze Learning"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Prefrontal Cortex"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["metabolism"], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": ["metabolism"], "DescriptorName": "Superoxide Dismutase"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Neurotoxicology. 2016 Jan;52:1-11", "ArticleIdList": ["26542248"]}, {"Citation": "Mutagenesis. 2016 Jan;31(1):35-41", "ArticleIdList": ["26188195"]}, {"Citation": "Appl Microbiol Biotechnol. 2011 Apr;90(2):679-87", "ArticleIdList": ["21191789"]}, {"Citation": "Neurobiol Aging. 2001 Sep-Oct;22(5):773-86", "ArticleIdList": ["11705637"]}, {"Citation": "J Pharmacol Exp Ther. 2007 Oct;323(1):78-84", "ArticleIdList": ["17636007"]}, {"Citation": "Oxid Med Cell Longev. 2016;2016:2075915", "ArticleIdList": ["26798413"]}, {"Citation": "Free Radic Biol Med. 2012 Feb 15;52(4):781-93", "ArticleIdList": ["22198265"]}, {"Citation": "Brain Res. 2016 Aug 1;1644:149-60", "ArticleIdList": ["27174003"]}, {"Citation": "Oxid Med Cell Longev. 2014;2014:893212", "ArticleIdList": ["25478064"]}, {"Citation": "Toxicol Sci. 2004 May;79(1):112-22", "ArticleIdList": ["14976349"]}, {"Citation": "Metab Brain Dis. 2015 Aug;30(4):935-42", "ArticleIdList": ["25600690"]}, {"Citation": "Toxicol In Vitro. 2015 Oct;29(7):1416-24", "ArticleIdList": ["26052022"]}, {"Citation": "Behav Brain Res. 2016 Feb 15;299:141-6", "ArticleIdList": ["26592165"]}, {"Citation": "Arch Med Sci. 2015 Dec 10;11(6):1296-302", "ArticleIdList": ["26788093"]}, {"Citation": "Pharm Biol. 2016 Sep;54(9):1528-38", "ArticleIdList": ["26810454"]}, {"Citation": "Mol Biosyst. 2016 Oct 20;12 (10 ):3088-97", "ArticleIdList": ["27460631"]}, {"Citation": "Chem Biol Interact. 2006 Oct 27;163(1-2):38-53", "ArticleIdList": ["16970935"]}, {"Citation": "Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):395-403", "ArticleIdList": ["15706086"]}, {"Citation": "Fundam Appl Toxicol. 1995 Nov;28(1):9-17", "ArticleIdList": ["8566488"]}, {"Citation": "Neuropsychopharmacology. 2007 Mar;32(3):531-41", "ArticleIdList": ["16760923"]}, {"Citation": "Environ Health Perspect. 1999 Feb;107 Suppl 1:207-17", "ArticleIdList": ["10229719"]}, {"Citation": "J Eur Acad Dermatol Venereol. 2003 Nov;17(6):663-9", "ArticleIdList": ["14761133"]}, {"Citation": "Inflammation. 2016 Dec;39(6):1918-1929", "ArticleIdList": ["27561645"]}, {"Citation": "J Neuroinflammation. 2011 Feb 15;8:15", "ArticleIdList": ["21324129"]}, {"Citation": "Biomed Pharmacother. 2016 Oct;83:1057-1063", "ArticleIdList": ["27544549"]}, {"Citation": "Behav Brain Res. 2015 Jul 15;288:1-10", "ArticleIdList": ["25869780"]}, {"Citation": "Springerplus. 2015 Aug 21;4:438", "ArticleIdList": ["26312203"]}, {"Citation": "J Immunotoxicol. 2010 Oct-Dec;7(4):333-43", "ArticleIdList": ["20958156"]}, {"Citation": "Neurochem Res. 2013 Aug;38(8):1661-71", "ArticleIdList": ["23686346"]}, {"Citation": "Arch Pharm Res. 2009 Aug;32(8):1163-76", "ArticleIdList": ["19727608"]}, {"Citation": "Toxicol Sci. 2008 Oct;105(2):331-41", "ArticleIdList": ["18628252"]}, {"Citation": "Teratog Carcinog Mutagen. 2002;22(2):113-28", "ArticleIdList": ["11835289"]}, {"Citation": "Br J Nutr. 2009 Aug;102(4):502-5", "ArticleIdList": ["19534845"]}, {"Citation": "Toxicology. 2007 Feb 12;230(2-3):126-36", "ArticleIdList": ["17157429"]}, {"Citation": "Toxicology. 1996 Dec 18;114(3):207-21", "ArticleIdList": ["8980710"]}, {"Citation": "Environ Sci Technol. 2011 Jul 1;45(13):5791-7", "ArticleIdList": ["21671678"]}, {"Citation": "FEBS Lett. 2000 Apr 28;472(2-3):196-202", "ArticleIdList": ["10788610"]}, {"Citation": "Brain Res Bull. 2016 Mar;121:48-58", "ArticleIdList": ["26772626"]}, {"Citation": "Front Aging Neurosci. 2015 May 05;7:65", "ArticleIdList": ["25999851"]}, {"Citation": "J Pharmacol Sci. 2015 May;128(1):35-46", "ArticleIdList": ["26003084"]}, {"Citation": "Neurotoxicology. 2010 Jun;31(3):310-6", "ArticleIdList": ["20211647"]}, {"Citation": "Toxicol Sci. 2004 Jul;80(1):83-91", "ArticleIdList": ["15141106"]}, {"Citation": "Int Immunopharmacol. 2007 Dec 5;7(12):1552-8", "ArticleIdList": ["17920532"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "12", "Day": "10"}, {"Year": "2017", "Month": "8", "Day": "11"}, {"Year": "2017", "Month": "8", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "7", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "8", "Day": "28", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["28844098", "10.1007/s11011-017-0095-0", "10.1007/s11011-017-0095-0"]}}], "PubmedBookArticle": []}